HEALTH● LOWJul 17 · Jul 17, 2026, 1:30 AM
Telix Completes Patient Enrollment in TLX591 - Px ( Illuccix ) Japan Phase 3 Study
vietnamtribune.com · Vietnam
Telix has completed patient enrollment for its TLX591-Px (Illuccix) Phase 3 study in Japan. This marks a milestone in the development of a new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH43m agoRed hexagon on your snack pack: What FSSAI’s new proposed warning label means | ExplainedThe HinduHEALTH2h agoRotten meat, spoiled milk seized across Bengal as food safety raids widenThe HinduHEALTH2h ago'Social jet lag': Why mismatched sleep schedules could be fuelling anxiety in teenagersEuroNews [en]HEALTH2h agoRiverview Farms expansion endangers clean water , public healthminnpost.com · United States